June 20, 2018

Ingrid A. Beattie, PhD

Ingrid’s practice emphasizes patent prosecution in the area of biotechnology, particularly in the fields of molecular biology, immunology, microbiology, cardiovascular medicine, clinical diagnostics, and medical devices, and includes advising clients on issues relating to patent portfolio management and licensing. She has been a frequent speaker at Biotechnology Industry Organization (BIO) conferences.

Prior to joining Mintz Levin, Ingrid was a technology transfer associate at the Dana-Farber Cancer Institute, and then practiced at another prominent Boston law firm.

Articles in the National Law Review database by Ingrid A. Beattie, PhD

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Wednesday, June 27, 2018